Nombre de documents

24

CV de Catherine Baugé


Article dans une revue14 documents

Communication dans un congrès3 documents

  • Céline Bazille, Nicolas Girard, Karim Boumediene, Catherine Baugé. Thérapie épigénétique avec le 3-deazaneplanocin (DZNep), un inhibiteur de l'histone méthyl-tranférase EZH2, traitement futur des chondrosarcomes de haut grade?. 7ème journé de la recherche, Jun 2015, Caen, France. <hal-01149723>
  • Nicolas Girard, Céline Bazille, Eva Lhuissier, Hervé Benateau, Karim Boumediene, et al.. Epigenetic therapy: a treatment for chondrosarcoma ?. 14th FEBS Young Scientists' Forum, Aug 2014, Paris, France. <hal-01149665>
  • Catherine Baugé. Inhibitors of the histone methylase EZH2, a new anti-tumoral therapy ?. 3rd world congress on cancer science and therapy, Oct 2013, San Francisco, United States. <hal-01149731>

Chapitre d'ouvrage1 document

  • Catherine Baugé, K. Boumediene. Interleukin-1 in osteoarthritis.. Kevin V Urbano. Advances in Genetics Research, 10, Nova publication, pp.115-128, 2013. <hal-01149649>

Poster6 documents

  • Juliette Aury-Landas, Morgane Barreau, Nicolas Girard, Eva Lhuissier, Karim Boumediene, et al.. Molecular characterization of commonly used chondrosarcoma cell lines. The european human genetics conference 2015, Jun 2015, Glasgow, United Kingdom. <hal-01149676>
  • Catherine Baugé, Juliette Aury-Landas, Sylvain Leclercq, Christian Marcelli, Karim Boumediene. Missing heritability in primary osteoarthritis: the Exorhum project. The european human genetics conference 2015, Jun 2015, Glasgow, United Kingdom. <hal-01149680>
  • Nicolas Girard, Eva Lhuissier, Olivier Cauvard, A. Batalla, Céline Bazille, et al.. Comparative study of the sensibility of chondrosarcoma to DNA damaging agents. FEBS-EMBO 2014 congress, Aug 2014, Paris, France. <hal-01149694>
  • Nicolas Girard, Céline Bazille, Eva Lhuissier, Hervé Benateau, Karim Boumediene, et al.. Epigenetic therapy; a promising treatment for chondrosarcoma?. FEBS-EMBO 2014 congress, Aug 2014, Paris, France. <hal-01149700>
  • Nicolas Girard, Céline Bazille, Eva Lhuissier, Hervé Benateau, Antonio Llombart-Bosch, et al.. 3-deazaneplanocin A (DZNep), an inhibitor of histone methyltransferase EZH2, induces apoptosis and reduces cell migration in chondrosarcoma cells.. 23rd biennial congress of the european association for cancer research, Jul 2014, Munich, Germany. <hal-01149710>
  • Eva Lhuissier, Nicolas Girard, Olivier Cauvard, Céline Bazille, Hervé Bénateau, et al.. Comparative study of chondrosarcomas response to DNA damage. Impact of HIF2 expression. 23rd biennial congress of the european association for cancer research, Jul 2014, Munich, Germany. <hal-01149717>